Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
RedShiftBio logo — See Change

RedShiftBio

See Change

Founded 2005 United States United States 31 employees Series E Total: $65.75M Biotechnology, Design +3

General Information

Company Name RedShiftBio
Founded Year 2005
Location United States United States +1
Employees 31
Industries Biotechnology, Design, Enterprise Software +2
Funding Stage Series E
Social

Get notified when RedShiftBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About RedShiftBio

RedShiftBio, with the slogan "See Change," is revolutionizing protein structure and concentration analysis. The company's proprietary life sciences platform utilizes Microfluidic Modulation Spectroscopy (MMS) and high-powered quantum cascade lasers to deliver precise measurements of molecular structure. This technology, available in the fully-automated Aurora and Apollo systems, is essential for assessing the safety, efficacy, and stability of biomolecules and their raw materials. RedShiftBio also provides support to biopharmaceutical manufacturing through HaLCon, a bioprocess analytics platform designed to measure protein titer at the time of need. Established in 2005 and headquartered in the United States, the company boasts an experienced management team and collaborates with prominent industry leaders. RedShiftBio's global impact is evident through its presence in leading biopharmaceutical companies and CDMOs worldwide and its collaborative centers in different locations including Boxborough, MA, Oxford, UK, Brussels, Belgium, and Redwood Shores, CA. The company has secured a significant $20.00M Series E investment on 18 October 2021, with backing from Waters Corporation, Illumina Ventures, and Technology Venture Partners. Additionally, an undisclosed leading life science company has contributed to the company's success. RedShiftBio's innovative approach, strong investor support, and commitment to advancing research, development, and manufacturing make it a promising player in the Biotechnology, Enterprise Software, and Manufacturing industries.

Taxonomy: biopharmaceuticals, protein analysis, bioprocess analytics, spectroscopy, quantum cascade lasers, molecular structure, instrumentation, biomolecule stability, biopharmaceutical manufacturing, microfluidic modulation spectroscopy, technology, venture capital, innovation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series E •••••• 3
Investor Investor
•••• •••• 		18 Oct 2021
Series D •••••• 1 •••• •••• 29 Jan 2020
Series C •••••• 2
Investor
•••• •••• 		14 Mar 2017
Venture Round •••••• - 02 Oct 2015
Venture Round •••••• - 03 Apr 2014

View All 7 Funding Rounds

RedShiftBio Alternatives & Competitors

RedShiftBio vs
High Q Technologies
High Q Technologies Canada

EPR for Protein Dynamics

Grant
23 employees
Information Technology
Compare RedShiftBio vs High Q Technologies
RedShiftBio vs
Creative Biostructure
Creative Biostructure United States

Our Mission is to Develop Creative Structure-based Therapies

201-500 employees
Biopharma, Biotechnology
RedShiftBio vs
Advanced Protein Technologies Corp.,
Advanced Protein Technologies Corp., Korea South

Advanced Protein Technologies Corp.(APTech) is a biotechnology company whose business goal is proces...

10 employees
Biopharma, Biotechnology
Also compare with: RedShiftBio vs NanoImaging Services NanoImaging Services RedShiftBio vs SARomics Biostructures AB SARomics Biostructures AB

FAQ About RedShiftBio

See Change
RedShiftBio was founded in 2005.
RedShiftBio is headquartered in United States.
RedShiftBio operates in the following industries: Biotechnology, Design, Enterprise Software, Life Sciences, Manufacturing.
RedShiftBio has approximately 31 employees.
RedShiftBio has completed 7 funding rounds, raising a total of $65.75M. The latest funding stage is Series E.
Top alternatives and competitors to RedShiftBio include High Q Technologies , Creative Biostructure, Advanced Protein Technologies Corp.,, NanoImaging Services, SARomics Biostructures AB. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RedShiftBio and High Q Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors RedShiftBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy